Single cell study of bladder cancer chemotherapy (PDX scRNA data)

Key Points

• This research aims to explore how lipid oxidation in cancer-associated fibroblasts affects CD8+ T-cell activity and treatment responses in bladder cancer.
• Analyzed single-cell RNA sequencing (scRNA) data from patient-derived xenografts (PDX)
• Evaluated the interactions between cancer-associated fibroblasts and CD8+ T-cells
• Assessed therapeutic responses based on lipid oxidation levels
• Lipid oxidation reprogramming in fibroblasts significantly enhanced CD8+ T-cell cytotoxicity
• Improved therapeutic responses were observed in models treated with chemotherapy
• The findings support the potential of targeting lipid metabolism in enhancing cancer immunotherapy